List of works - Michael F. McEntee

A novel intradural extramedullary spinal cord tumor in young dogs.

scientific article published on January 1988

Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens

scientific article published on 01 January 1987

Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity

scientific article

Colorectal ganglioneuromatosis in a young female dog (Lhasa Apso).

scientific article

Dietary polyunsaturated fatty acids and colorectal neoplasia.

scientific article

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

scientific article

Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells

scientific article

Erythema multiforme associated with zonisamide in a dog.

scientific article published on 20 July 2015

Granulated round cell tumor of cats

scientific article published in March 1993

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

scientific article published on August 2008

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

scientific article

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

scientific article published on 01 September 2004

Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors

scientific article published in June 1997

Large granular lymphocyte tumor in a horse

scientific article published in January 1989

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

scientific article published in August 1996

Meningocerebral hemangiomatosis resembling Sturge-Weber disease in a horse.

scientific article

Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene

scientific article published in July 1996

Mthfd1 is a modifier of chemically induced intestinal carcinogenesis ⬇️

scientific article published on December 14, 2010

Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia

scientific article published on 19 September 2006

Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy

scientific article published on 11 July 2011

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

scientific article published on September 2008

Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice

scientific article published in November 2006

Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.

scientific article

Review paper: Cancer chemopreventive compounds and canine cancer.

scientific article published on 09 March 2009

Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis

scientific article published in January 2002

Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.

scientific article

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

scientific article published on October 2005

The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid

scientific article published on 08 October 2013

Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.

scientific article published on May 2003

Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.

scientific article published on 29 September 2011

Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.

scientific article

Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells

scientific article

List of works by Michael F. McEntee

A novel intradural extramedullary spinal cord tumor in young dogs.

Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens

Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity

Colorectal ganglioneuromatosis in a young female dog (Lhasa Apso).

Dietary polyunsaturated fatty acids and colorectal neoplasia.

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells

Erythema multiforme associated with zonisamide in a dog.

Granulated round cell tumor of cats

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors

Large granular lymphocyte tumor in a horse

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

Meningocerebral hemangiomatosis resembling Sturge-Weber disease in a horse.

Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene

Mthfd1 is a modifier of chemically induced intestinal carcinogenesis ⬇️

Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia

Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice

Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.

Review paper: Cancer chemopreventive compounds and canine cancer.

Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis

Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid

Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.

Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.

Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.

Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells